NORAK BIOSCIENCES

norak-biosciences-logo

Norak Biosciences, Inc., headquartered in Research Triangle Park, NC, is a private biotechnology company. Norak is utilizing its proprietary Transfluor technology to become a world leader in the discovery and development of drugs that regulate G protein-coupled receptors.

#SimilarOrganizations #Financial #More

NORAK BIOSCIENCES

Social Links:

Industry:
Biotechnology Health Care Life Science Pharmaceutical

Founded:
1999-01-01

Address:
Morrisville, North Carolina, United States

Country:
United States

Total Employee:
1+

Status:
Active

Total Funding:
13 M USD

Technology used in webpage:
Google Analytics Nginx Google Analytics Classic


Similar Organizations

not_available_image

Tissue Genetics Inc

Tissue Genetics is a diagnostics company with unique technology for improving the diagnosis, treatment and prevention of genetic diseases.

Investors List

the-aurora-funds_image

The Aurora Funds

The Aurora Funds investment in Series B - Norak Biosciences

noro-moseley-partners_image

Noro-Moseley Partners

Noro-Moseley Partners investment in Series B - Norak Biosciences

alexandria-real-estate-equities_image

Alexandria Real Estate Equities

Alexandria Real Estate Equities investment in Series B - Norak Biosciences

koch-enterprises-inc_image

Koch Enterprises

Koch Enterprises investment in Series B - Norak Biosciences

intersouth-partners_image

Intersouth Partners

Intersouth Partners investment in Series B - Norak Biosciences

mitsui-ventures_image

Mitsui Global Investment

Mitsui Global Investment investment in Series B - Norak Biosciences

More informations about "Norak Biosciences"

Home | Norak Biosciences, Inc.

Norak Biosciences, Inc. is a private biotechnology company based in Research Triangle Park, NC, utilizing its proprietary Transfluor® technology to become a world leader in the discovery …See details»

Norak Biosciences - Crunchbase Company Profile & Funding

Norak Biosciences, Inc., headquartered in Research Triangle Park, NC, is a private biotechnology company. Norak is utilizing its proprietary Transfluor technology to become a world leader in …See details»

Norak Biosciences Company Profile | Management and Employees …

Norak Biosciences, Inc., headquartered in Research Triangle Park, NC, is a private biotechnology company utilizing its proprietary Transfluor® technology to become a world leader in the …See details»

Norak Biosciences - Funding, Financials, Valuation & Investors

Norak Biosciences is a biotechnology company that uses proprietary technology for the discovery and development of drugs.See details»

Norak Biosciences - Drug pipelines, Patents, Clinical trials - Synapse

Explore Norak Biosciences with its drug pipeline, therapeutic area, technology platform, .See details»

Norak Biosciences - Crunchbase

Norak Biosciences is a biotechnology company that uses proprietary technology for the discovery and development of drugs.See details»

Norak | Norak Biosciences, Inc.

Norak Transfluor® Publications . 1. Robert Oakley, Christine Hudson, Rachael Cruickshank, Diane Meyers, Richard. Payne, Jr., Shay Rhem, and Carson Loomis. (2002). The Cellular …See details»

Venture 2003: Just the Facts About Norak Biosciences

Apr 18, 2003 · Norak Biosciences, Inc. Type of Company: Private Biotechnology Address: P. O. Box 14769, RTP, NC 27709 Phone: 919-248-8000 Web Site: www.norakbio.com Management …See details»

Norak Biosciences, Inc. Partners With Purdue Pharmaceuticals

Oct 13, 2004 · Norak Biosciences, Inc., headquartered in Research Triangle Park, NC, is a private biotechnology company. Norak is utilizing its proprietary Transfluor technology to become a …See details»

Success Stories | Norak Biosciences, Inc.

Transfluor® assay by iCyteâ„¢ imaging cytometer - An advanced cell based screening technology applicable to GPCRs - Kazuo Ozawa Etsuo Shinohara Sachiko Karaki Olympus Co. Genome …See details»

Norak Biosciences Inc. :: Scrip

Mar 1, 2002 · Norak's founders think that beta-arrestin's movement from within the body of the cell to the membrane-bound receptor is a specific marker of GPCR receptor activation-and their …See details»

Norak¿s GPCR Technology Displayed In Amersham Deal

Aug 30, 2001 · Norak Biosciences Inc.¿s mission is to become a global leader in the discovery and development of drugs that regulate G protein-coupled receptors (GPCRs). The …See details»

Norak Biosciences Inc.

Norak's founders think that beta-arrestin's movement from within the body of the cell to the membrane-bound receptor is a specific marker of GPCR receptor activation-and their method …See details»

Norak Biosciences - Tech Stack, Apps, Patents & Trademarks

Norak Biosciences is a biotechnology company that uses proprietary technology for the discovery and development of drugs.See details»

Xsira Pharmaceuticals Inc | www.inknowvation.com

Previously doing bsuiness as Norak Biosciences, Inc, Xsira Pharmaceuticals, Inc., is a product-based biopharmaceutical company focused in the discovery and development of the next …See details»

Xsira, new name for Norak Biosciences - BioWorld

Jan 10, 2005 · Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, …See details»

Norak Biosciences obtains additional rights through issuance of …

Norak Biosciences Inc announced an additional patent issued covering compositions and methods that protect its Transfluor technology in Australia. The newly issued patent claims …See details»

Will New IP for GPCR Screening Assays Lead to Windfall for Norak ...

Aug 10, 2004 · Norak Biosciences last week strengthened its cell-based assay intellectual property portfolio when it was issued a new US patent for a broad suite of assays used to …See details»

Antibodies | Norak Biosciences, Inc.

THE MabIgX® TECHNOLOGY - AN ADVANCED CLASS OF MONOCLONAL ANTIBODIES. Under the strategic agreement with Kenta Biotech, Aridis Pharmaceuticals (USA) has acquired …See details»

Koch Enterprises - Funding, Financials, Valuation & Investors

Feb 5, 2002 · Koch Enterprises has invested in Norak Biosciences on Feb 5, 2002. This investment - Series B - Norak Biosciences - was valued atSee details»

linkstock.net © 2022. All rights reserved